Stemline Therapeutics, Inc. drugs

2 results
  • elzonris - tagraxofusp injection, solution

    (Tagraxofusp)
    Stemline Therapeutics, Inc.
    Elzonris treats blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients aged 2 years and older.
  • orserdu - elacestrant tablet, film coated

    (Elacestrant)
    Stemline Therapeutics, Inc.
    Orserdu treats ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer in postmenopausal women or adult men whose disease has progressed after at least one prior endocrine therapy.